.jpg?format=webp&width=780)
This study aimed to evaluate the safety and effectiveness of the InterStim Micro system, which is used for sacral neuromodulation in patients with overactive bladder. The study enrolled 68 patients who completed follow-up visits at 3 and 6 months after implantation. The results showed a significant improvement in quality of life score at both follow-up visits and a reduction in urinary incontinence episodes and voids per day. The incidence of adverse events was comparable to previously reported rates for sacral neuromodulation. The study confirms the safety and clinical performance of the InterStim Micro device for patients with overactive bladder.
Like
Save
Share